HSP90AA1 and renal fibrosis: The results suggested that 17 core compounds such as quercetin, kaempferol, luteolin, naringenin, and 23 core targets such as NCOA2, HSP90AA1, and PTGS1 might play an important role in JPYSF-treated renal fibrosis.